Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
KUAISHOU-W
01024
5
JD HEALTH
06618
| (Q2)Sep 30, 2025 | (Q1)Jun 30, 2025 | (FY)Mar 31, 2025 | (Q3)Dec 31, 2024 | (Q2)Sep 30, 2024 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 2.14%641.65B | 1.12%580.8B | 7.62%2.53T | 8.16%632.82B | 8.69%628.21B | 7.44%574.38B | 10.07%2.35T | 7.55%651.3B | 5.41%585.1B | 12.41%577.99B |
| Cost of revenue | 4.17%429.23B | 1.69%373.44B | 8.53%1.66T | 10.78%415.1B | 7.89%412.06B | 6.63%367.25B | 10.09%1.53T | 7.23%427.88B | 3.37%374.7B | 13.69%381.91B |
| Gross profit | -1.72%212.43B | 0.11%207.35B | 5.92%868.61B | 3.48%217.71B | 10.23%216.15B | 8.90%207.13B | 10.02%820.1B | 8.16%223.42B | 9.25%210.39B | 9.99%196.08B |
| Operating expense | -12.08%189.62B | -3.03%194.71B | 6.07%803.47B | -1.47%189.97B | 15.52%215.68B | 11.54%200.8B | 13.63%757.46B | 18.27%197.94B | 9.28%192.8B | 13.52%186.69B |
| Selling and administrative expenses | -12.41%190.4B | -2.28%196.98B | 6.38%818.95B | 2.40%200.48B | 14.52%217.38B | 10.75%201.58B | 11.87%769.81B | 10.13%202.2B | 9.97%195.78B | 13.77%189.82B |
| -General and administrative expense | -12.41%190.4B | -2.28%196.98B | 6.38%818.95B | 2.40%200.48B | 14.52%217.38B | 10.75%201.58B | 11.87%769.81B | 10.13%202.2B | 9.97%195.78B | 13.77%189.82B |
| Total other operating income | -54.31%779M | 192.41%2.27B | 25.28%15.48B | 252.18%10.51B | -45.41%1.71B | -60.80%777M | -42.66%12.35B | -73.75%4.27B | 85.00%2.98B | 31.05%3.12B |
| Operating profit | 4,681.13%22.81B | 99.65%12.64B | 3.99%65.14B | 57.68%27.75B | -94.92%477M | -37.74%6.33B | -20.52%62.64B | -34.99%25.48B | 8.89%17.6B | -32.06%9.39B |
| Net non-operating interest income (expenses) | -302.76%-1.69B | -82.90%311M | -11.46%510M | -71.33%-2.18B | 440.26%832M | 20.54%1.82B | 116.08%576M | 130.49%186M | -434.87%-1.27B | 106.85%154M |
| Non-operating interest income | -65.63%661M | -47.86%2.24B | 16.51%11.04B | -21.96%462M | -61.11%1.92B | 30.28%4.3B | 109.49%9.47B | 71.95%2.95B | -59.45%592M | 564.65%4.95B |
| Non-operating interest expense | 115.22%2.35B | -22.19%1.93B | 18.32%10.53B | 41.72%2.64B | -77.23%1.09B | 38.48%2.48B | 9.77%8.9B | 18.84%2.76B | 9.84%1.87B | 60.18%4.79B |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | -27.01%1.47B | 9.98%1.86B | 2.23%5.73B | -2.02%1.7B | 15.02%2.01B | 2.36%1.69B | -8.91%5.6B | 0.43%467M | -3.57%1.73B | -4.21%1.75B |
| Special income (charges) | -111.79%-1.31B | -784.29%-619M | ||||||||
| Less:Negative goodwill immediately recognized | ---- | ---- | 111.79%1.31B | ---- | ---- | ---- | 784.29%619M | ---- | ---- | ---- |
| Other non-operating income (expenses) | ||||||||||
| Income before tax | 579.78%22.59B | 50.50%14.82B | 2.73%70.07B | 50.99%27.26B | -70.58%3.32B | -26.17%9.84B | -16.12%68.2B | -34.55%25.52B | 1.91%18.06B | -15.73%11.3B |
| Income tax | 398.39%7.1B | 90.99%4.58B | 0.10%23.98B | 152.08%8.05B | -68.67%1.43B | -49.59%2.4B | -6.65%23.96B | -1.18%11.46B | -33.55%3.19B | -19.95%4.55B |
| Net income | 715.96%15.49B | 37.46%10.24B | 4.16%46.08B | 29.28%19.21B | -71.86%1.9B | -13.20%7.45B | -20.49%44.24B | -48.68%14.06B | 15.10%14.86B | -12.62%6.75B |
| Net income continuous operations | 715.96%15.49B | 37.46%10.24B | 4.16%46.08B | 29.28%19.21B | -71.86%1.9B | -13.20%7.45B | -20.49%44.24B | -48.68%14.06B | 15.10%14.86B | -12.62%6.75B |
| Noncontrolling interests | 32.01%565M | 265.81%582M | 466.67%374M | 215.08%627M | 686.30%428M | -62.50%-351M | -94.82%66M | -65.94%156M | -48.71%199M | -118.39%-73M |
| Net income attributable to the company | 915.10%14.92B | 23.81%9.66B | 3.47%45.71B | 26.75%18.59B | -78.44%1.47B | -11.34%7.8B | -18.74%44.18B | -48.39%13.9B | 17.08%14.66B | -6.88%6.82B |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 915.10%14.92B | 23.81%9.66B | 3.47%45.71B | 26.75%18.59B | -78.44%1.47B | -11.34%7.8B | -18.74%44.18B | -48.39%13.9B | 17.08%14.66B | -6.88%6.82B |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 952.61%26.21 | 30.16%16.96 | 7.62%78.11 | 32.28%31.84 | -77.77%2.49 | -9.76%13.03 | -17.64%72.58 | -47.83%22.87 | 17.07%24.07 | -5.80%11.2 |
| Diluted earnings per share | 951.41%26.18 | 30.11%16.94 | 7.57%78.04 | 32.34%31.84 | -77.75%2.49 | -9.77%13.02 | -17.65%72.55 | -47.83%22.86 | 17.02%24.06 | -5.89%11.19 |
| Dividend per share | 5.26%20 | 0 | 5.56%38 | 0 | 5.56%19 | 0 | 5.88%36 | 5.88%18 | 0 | 5.88%18 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |